Unlearn - Advancing AI to power the future of medicine

🚀 Unlearn.ai is revolutionizing medicine with AI! 🏥 Their TrialPioneer tool creates digital twins for quicker clinical trials in areas like Alzheimer’s and Rheumatoid Arthritis. 🧠🩺 Say goodbye to trial and error in medicine! #AI #HealthTech #Innovation

TrialPioneer offers digital twins for confident and rapid clinical trials in various medical fields.
They specialize in neuroscience, immunology, metabolic diseases, and more.
Clinical trial areas include Alzheimer’s disease, Asthma, Rheumatoid Arthritis, and many others.
TwinRCTsTM are clinical trials using patients' digital twins to accelerate study enrollment.
TwinRCTs reduce enrollment time in late-stage studies compared to traditional designs.
They enable better observation of treatment effects in early-stage studies without increasing patient numbers.
TwinRCTs increase the chances for study participants to receive experimental treatments due to smaller control groups.
Digital twins in clinical trials forecast patients' future health based on historical data.
Unlearn.ai focuses on using artificial intelligence to enhance medical research and clinical methods.